Altimmune's existence depends almost entirely on the outcome of the Phase 2 trial for pemvidutide in MASH. Learn why ALT ...

Madrigal Pharmaceuticals, Inc. (Nasdaq: MDGL) has announced the release of its fourth-quarter and full-year 2024 financial ...

After hours: February 14 at 6:27:32 PM EST Loading Chart for MDGL ...

The Newberry Consort used the Valentine’s Day weekend to present a concert which examined the many aspects of love. This ...

The Janus Henderson Concentrated Growth Managed Account Portfolio returned 2.44% (gross) and the Russell 1000® Growth Index ...

Find out which stocks top investors, including Warren Buffett, are allocating significant portions of their portfolios to.

After months of speculation, it seems the “OMG” era has come to an end for the New York Mets. On Wednesday, Mets president of baseball operations David Stearns ...

With the February signing of soon-to-be franchise home run champion Pete Alonso, the Mets were set at virtually every ...

May 2, the inaugural festival brings concerts, augmented reality experiences, exhibitions, films and more in celebration of ...

Madrigal said that all patients enrolled in MAESTRO-NASH - which include up to 2,000 in total - are continuing on therapy after the initial 52-week treatment period.